Literature DB >> 3296098

Mycobacteria other than Mycobacterium tuberculosis: review of microbiologic and clinical aspects.

G L Woods, J A Washington.   

Abstract

The rate of isolation of mycobacteria other than Mycobacterium tuberculosis (MOTT) has increased over the past several years; in some areas the isolation rate for Mycobacterium avium-Mycobacterium intracellulare has surpassed that for M. tuberculosis. Simultaneously, the spectrum of clinical manifestations with the various species has widened. Outbreaks of disease due to Mycobacterium chelonae have occurred in renal dialysis patients. New species have been described: Mycobacterium malmoense is primarily a pulmonary pathogen, and Mycobacterium haemophilum has been recovered from cutaneous lesions in immunosuppressed patients. In addition, reports of disease due to species generally considered saprophytic have become more numerous. In this review, the epidemiologic, pathologic, and clinical features of the individual MOTT species are discussed. A brief summary of mycobacteria isolated at the Cleveland Clinic foundation between 1982 and 1985 is also presented.

Entities:  

Mesh:

Year:  1987        PMID: 3296098     DOI: 10.1093/clinids/9.2.275

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  47 in total

1.  PCR-enzyme-linked immunosorbent assay and partial rRNA gene sequencing: a rational approach to identifying mycobacteria.

Authors:  S Patel; M Yates; N A Saunders
Journal:  J Clin Microbiol       Date:  1997-09       Impact factor: 5.948

2.  Environmental factors affecting the occurrence of mycobacteria in brook waters.

Authors:  E K Iivanainen; P J Martikainen; P K Väänänen; M L Katila
Journal:  Appl Environ Microbiol       Date:  1993-02       Impact factor: 4.792

Review 3.  Agents of newly recognized or infrequently encountered mycobacterial diseases.

Authors:  L G Wayne; H A Sramek
Journal:  Clin Microbiol Rev       Date:  1992-01       Impact factor: 26.132

4.  Presumptive identification of Mycobacterium xenopi with the radiometric Bactec system.

Authors:  P P Koemoth; R Fraselle; J M Corrêa de Brito; M Brock
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-08       Impact factor: 3.267

5.  Effect of ofloxacin combined with Lactobacillus casei against Mycobacterium fortuitum infection induced in mice.

Authors:  H Tomioka; K Sato; H Saito
Journal:  Antimicrob Agents Chemother       Date:  1990-04       Impact factor: 5.191

Review 6.  Antimycobacterial susceptibility testing: present practices and future trends.

Authors:  C B Inderlied
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-11       Impact factor: 3.267

Review 7.  Susceptibility testing of Mycobacterium avium complex isolates.

Authors:  L Heifets
Journal:  Antimicrob Agents Chemother       Date:  1996-08       Impact factor: 5.191

Review 8.  Infections in solid-organ transplant recipients.

Authors:  R Patel; C V Paya
Journal:  Clin Microbiol Rev       Date:  1997-01       Impact factor: 26.132

9.  Mycobacterium marinum persists in cultured mammalian cells in a temperature-restricted fashion.

Authors:  L Ramakrishnan; S Falkow
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

10.  Comparison of methods for isolation of mycobacteria from water.

Authors:  M Neumann; R Schulze-Robbecke; C Hagenau; K Behringer
Journal:  Appl Environ Microbiol       Date:  1997-02       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.